Mediaboss Marketing

The list of concerns around the use of artificial intelligence seems to grow with every passing week.

Issues around bias, the use of AI for deepfakevideos and audio,misinformation, governmental surveillance, securityand failure of the technology to properly identify the simplest of objects have created a cacophony of concern about the technologys long-term future.

One software company recently released a study which showed only 25% of consumers would trust a decision made by systems using AI, and another report commissioned by KPMG International found that a mere 35% of information technology leaders had a high level of trust in their own organizations analytics.

Its a bumpy journey for AI as the technology world embarks on a new decade and key practitioners in the space are well aware that trust will ultimately determine how widely and quickly the technology becomes adopted throughout the world.

We want to build an ecosystem of trust,Francesca Rossi, AI ethics global leader at IBM Corp., said at the digitalEmTech Digital conference on Monday. We want to augment human intelligence, not replace it.

The EmTech Digital event, restructured into a three-day digital conference by MIT Technology Review after plans to hold it this month in San Francisco were canceled, was largely focused on trust in AI and how the tech industry was seeking to manage a variety of issues around it.

One of those issues is the use of deepfake AI tools to create genuine appearing videos or audio to deceive users. The use of deepfake videos has been rising rapidly, according to recent statistics provided by Deeptrace, which found an 84% rise in false video content versus a year ago.

Today more than ever we cannot believe what we see, and we also cannot believe what we hear,Delip Rao, vice president of research at AI Foundation, said during an EmTech presentation on Tuesday. This is creating a credibility crisis.

To help stem the flow of deepfakes into the content pool, the AI Foundation has launched a platform,Reality Defender, thatuses deepfake detection methods provided by various partners, including Google LLC and Facebook Inc. The nonprofit group recently extended its detection technology to include 2020 election campaigns in the U.S. as well.

As a generation, we have consumed more media than any generation before us and were hardly educated about how we consume it, Rao said. We cannot afford to be complacent. The technology behind deepfakes is here to stay.

AI has also come under fire for its use in facial recognition systems powered by a significant rise in the installation of surveillance cameras globally. A recent report by IHS Markit showed that China leads the world with 349 million surveillance cameras. The U.S. has 70 million cameras, yet it is close to China on a per capita basis with 4.6 people per camera installed.

The rise of AI-equipped cameras and facial recognition software has led to the development of a cottage industry on both sides of the equation. One Chinese AI company SenseTime has claimed the development of an algorithm which can identify a person whose facial features are obscured by a surgical mask and use thermal imaging to determine body temperature.

Meanwhile, a University of Maryland professor has developed a line of clothing, including hoodies and t-shirts, emblazoned with patterns specially designed to defeat surveillance camera recognition systems. All of that underscores the growing societal challenges faced by practitioners in the AI field.

The other complex problem affecting the AI industry involves cybersecurity. As adoption grows and the tools improve, the use of AI is not limited to white hat users. Black hat hackers have access to AI as well and they have the capability to use it.

Cybersecurity vendor McAfee Inc. has seen evidence that hackers may be employing AI to identify victims likely to be vulnerable to attack, according to Steve Grobman, senior vice president and chief technology officer at McAfee. Malicious actors can also use the technology to generate customized content as a way to sharpen spear phishing lures.

AI is a powerful tool for both the defenders and the attackers, Grobman said. AI creates a new efficiency frontier for the attacker. Were seeing a constant evolution of attack techniques.

The trust issues surrounding AI represent an important focus right now because the AI train has left the station and a lot of passengers are on board for the ride. AI has become a key element in improving operational efficiency for many businesses and a number of speakers at the event outlined how enterprises are employing the technology.

Frito Lay Inc. uses AI to analyze weather patterns and school schedules to determine when its corn chip inventory should be increased on store shelves. Global healthcare provider Novartis AG is using AI to support clinical trials and determine injection schedules for people with macular degeneration.

And when engineers at shipping giant DHL International saw how AI could be used to detect cats in YouTube videos, they wondered if the same approach could be taken to inspect shipping pallets for stackability in cargo planes.

These are small decisions were doing for load efficiency on over 500 flights per night, said Ben Gesing, DHLs director and head of trend research. At DHL, no new technology has been as pervasive or as fast-growing as AI.

Perhaps even more intriguing was the recent news that Salesforce Inc. has employed AI to undertake major research on protein generation. Earlier this month, Salesforce published a study which detailed a new AI system called ProGen that can generate proteins in a controllable fashion.

In a presentation Tuesday, Salesforce Chief ScientistRichard Socherdescribed how the company viewed AI as a double-edged strategy. One is the science fiction state, in which dreams of self-driving cars and big medical breakthroughs reside. The other is the electricity state, which uses technology such as natural language understanding to power chatbots.

AI is in this dual state right now, Socher said. At Salesforce, were trying to tackle both of those states. I truly believe that AI will impact every single industry out there.

If Socher is right, then every industry is going to have to deal with a way to engender trust in how it uses the technology. One EmTech speaker presented results from a recent Deloitte study which found that only one in five CEOs and executives polled had an ethical AI framework in place.

There are challenges ahead of us, said Xiaomeng Lu, senior policy manager at Access Partnership. We cant run away. We have to tackle them head on.

Show your support for our mission with our one-click subscription to our YouTube channel (below). The more subscribers we have, the more YouTube will suggest relevant enterprise and emerging technology content to you. Thanks!

Support our mission: >>>>>> SUBSCRIBE NOW >>>>>> to our YouTube channel.

Wed also like to tell you about our mission and how you can help us fulfill it. SiliconANGLE Media Inc.s business model is based on the intrinsic value of the content, not advertising. Unlike many online publications, we dont have a paywall or run banner advertising, because we want to keep our journalism open, without influence or the need to chase traffic.The journalism, reporting and commentary onSiliconANGLE along with live, unscripted video from our Silicon Valley studio and globe-trotting video teams attheCUBE take a lot of hard work, time and money. Keeping the quality high requires the support of sponsors who are aligned with our vision of ad-free journalism content.

If you like the reporting, video interviews and other ad-free content here,please take a moment to check out a sample of the video content supported by our sponsors,tweet your support, and keep coming back toSiliconANGLE.

Link:
As adoption of artificial intelligence accelerates, can the technology be trusted? - SiliconANGLE News

DMG Productions explores innovations in artificial intelligence for precision medicine.

JUPITER, Fla., March 26, 2020 /PRNewswire-PRWeb/ --During Q3/2020, Advancements with Ted Danson will focus on how technology is transforming precision medicine. Check your local listings for more info.

This segment of Advancements will discover how Ninety One Holdings, Inc. (Ninety One) aspires to advance precision medicine by combining state-of-the-art software technology with modern mathematical methods of data science, machine learning, and artificial intelligence.

"Ninety One is a cloud-native and AI technology company aspiring to lead the transformation into digital healthcare and Precision Medicine. It was founded on the conviction of fusing medical science with advanced mathematical modeling and big data technology. The first solution is an augmented intelligence, SaaS ecosystem automating and redesigning remote monitoring of implanted cardiac devices and wearables," said Dr. Eleonora Gashi, Co-founder and Medical Director at Ninety One.

Viewers will learn how Ninety One digitizes and transforms unstructured data from multiple sources into an error-free, efficient, and easy to use model. The show will also focus on Ninety One's ability to automate remote monitoring of CIEDs into a single-point, cloud-native application.

"Ninety One strongly believes that pursuing this mission with vigorous commitment and passion, while leveraging innovations in science, will have a material impact on disease diagnosis, treatment, and prevention," said Richard Simon, producer for the Advancements series.

About Ninety One: Ninety One Holding, Inc. is a privately-held, data science and cloud-native technology company, focusing on clinical advancements in predictive analytics and Precision Medicine. Ninety One automates the collection of data and reports from implanted cardiac devices and wearables digitizes, structures, and analyzes them with applied data science in a single-point, easy-to-use interface for patient care and innovation in research.

Ninety One's Global team of data scientists, software engineers, and modern mathematicians utilize artificial intelligence on vast amounts of data produced by these devices to predict disease episodes and disease progression.For more information please visit https://www.91.life.

About Advancements and DMG Productions: The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today's consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Simon at 866-496-4065.

SOURCE Advancements with Ted Danson

Read more:
Discover Breakthroughs in Automation and Artificial Intelligence on an Upcoming Episode of Advancements Television Series - Yahoo Finance

Brossard, Quebec, March 25, 2020 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (DIAGNOS or the Corporation) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces that it is participating in the Call to Action initiative implemented by the White House Office of Science and Technology Policy. DIAGNOS has accessed a significant dataset with the objective of analysing these medical documents with its AI Medical Platform, called FLAIRE, in order to identify key factors that could assist in the battle against the Coronavirus.

In response to the COVID-19 pandemic, the White House and a coalition of leading research groups have prepared the COVID-19 Open Research Dataset (CORD-19). CORD-19 is a resource of over 44,000 scholarly articles, including over 29,000 with full text, about COVID-19, SARS-CoV-2, and related coronaviruses. This dataset is provided to the global research community to apply recent advances in natural language processing and other AI techniques to generate new insights in support of the ongoing fight against this infectious disease. There is a growing urgency for these approaches because of the rapid acceleration in new coronavirus literature, making it difficult for the medical research community to keep up.

Call to Action (from the White House)

The White House is issuing a call to action to the world's artificial intelligence experts to develop text and data mining tools that can help the medical community develop answers to high priority scientific questions. The CORD-19 dataset represents the most extensive machine-readable coronavirus literature collection available for data mining to date. This allows the worldwide AI research community the opportunity to apply text and data mining approaches to find answers to questions within, and connect insights across, this content in support of the ongoing COVID-19 response efforts worldwide.

Mr. Andr Larente, CEO of Diagnos stated: Diagnos AI platform has been built to address the complexity of multiple sources of data that includes text mining, data mining and medical imaging. The proprietary technology has been developed over a number of years in order to identify medical challenges, for example cardio vascular issues have resulted in new tests to address hypertensive patient complications and to predict a potential stroke. The intention of FLAIRE in response to the White House Call to Action is to assist in resolving some of the issues caused by the virus by analyzing the dataset made available by the US authorities.

The Standing Committee on Emerging Infectious Disease and 21st Century Health Threats of the US and the WHO identified 10 scientific questions that are vital to address this international crisis. These questions include studying the transmission and incubation of the virus, risk factors for getting the COVID-19, the origin of the virus, and the proper medical practice for treating this disease.

Mr. Francis Bellido, PhD in Medical Microbiology and board member at Diagnos added: One outcome that is particularly remarkable in the COVID-19 crisis is that the majority of the deceased victims had one or several pre-condition(s) before the infection struck such as hypertension, diabetes, obesity or other Cardio Vascular issues, which are the sweet spots for the Diagnos diagnostic assisted platform. We believe that this virus could further alter the cartography of the retina in such patients, and if confirmed, creating the possibility of an additional facet to our existing detection tool for our existing patients.

Dr. Hadi Chakor, Chief Medical Officer at Diagnos added: One of the treatments for COVID-19 is the use of chloroquine or hydroxychloroquine. The recommendations of the American Academy of Ophthalmology on the screening of chloroquine (CQ) and hydroxychloroquine (HCQ) are very clear after taking high doses and for a long period of use, a rigorous follow-up with patients is required. These conditions represent the most severe risks of developing morphological alterations in the retina after treatment with chloroquine. Also, previous studies demonstrate clearly that chloroquine disrupts lysosomal function in retinal neurons and RPE. Modern screening should be based on primary AI-based automatic screening tests to assess the fundus plus optical spectral coherence tomography (SD OCT) exams. These investigations should look beyond the central macula to provide objective screening and to detect subtle changes on the retinal membrane.

The Corporation is also announcing a correction to its press release dated March 9th, 2020: The number of common shares that Mr. Tristram Coffin would hold assuming the exercise of stock warrants should read 11,047,561 instead of 10,624,560.About DIAGNOS

DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence (AI) platform FLAIRE. Diagnos can build application rapidly using the FLAIRE platform such as CARA (Computer Assisted Retina Analysis). CARA is an application that integrates with existing equipment (hardware and software) and processes at the point of care. CARAs Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is a cost-effective tool for screening large numbers of patients in real-time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration, European Union and other countries.

Additional information is available at http://www.diagnos.com and http://www.sedar.com.

This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publically update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Go here to see the original:
DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the US White House - Call to Action to Analyse and Transform...

The Spanish government is planning to test 80,000 people a day for coronavirus with the roll-out of robot testers.

Technology will be used to speed up testing of people in Spain, one of the countries hardest hit by the Covid-19 outbreak, with more than 200 deaths so far. According to Bloomberg, Spanish authorities now plan to increase daily testing from about 20,000 a day to 80,000, by using four robots to apply artificial intelligence (AI) to testing.

Speaking at a conference on Saturday 21 March, Raquel Yotti, head of Madrids health institute, said: A plan to automate tests through robots has already been designed and Spain has committed to buying four robots that will allow us to execute 80,000 tests per day.

Because of the ease that coronavirus spreads from person to person, testing has been identified as one of the best ways to control the disease. But testing has cost and resource limitations. Applying AI and robot technology could help overcome these problems, while reducing medical practitioners exposure to the virus.

No further details have been given about how the robots will work, but AI is increasingly being designed to work in the healthcare industry by automating some of the work of medical staff, giving them more time to treat patients.

The technology has proved successful in medical trials, including identifying cancer in breast scans.

A research paper from Google Health, published inNaturemagazine, has reported that machine learning, based on Googles TensorFlow algorithm, can be used to reduce false positives in breast cancer scans. A false positive is when a mammogram scan is incorrectly identified as cancerous, and a false negative is when it is wrongly diagnosed as not being cancerous.

In the Google Health paper, based on training an AI algorithm to identify breast cancer using a large representativedataset from the UK and the US, the researchers reported an absolute reduction of 5.7% in false positives in the US dataset, while the UK dataset showed a 1.2% reduction in false positives.

Read the rest here:
Coronavirus: Spain to use artificial intelligence to automate testing - ComputerWeekly.com

ATLANTA, March 25, 2020 (GLOBE NEWSWIRE) -- As many government and private institutions scramble to react to the unexpected COVID-19 pandemic, one telehealth company has been prepared for years to respond to this kind of crisis. LiveMD, a leading provider of global telehealth services, has a reliable, established, full-featured telehealth platform that allows anyone to use their phone to check their symptoms, track and self-report viruses such as COVID-19, and talk to a doctor. Plus it offers a verifiable track record of successful service delivery to patients in more than 42 countries worldwide. The company leverages the expertise of doctors in 53 distinct specialties, who are based in 30 different countries.

LiveMD offers an innovative app that can be downloaded directly from the Google Play store at http://bitly.com/livemdapp. With the LiveMD app, anyone can track the COVID-19 corona virus in their local area, regardless of where they live. They can self-report their corona virus status for tracking and covid-19 testing triaging, and connect with local government and medical agencies (such as test labs) for help and guidance. Their personal health information is kept private and secured.

As explained by LiveMD Founder and CEO Emeka Okwara, LiveMD is a global telehealth platform intended to serve anyone on this planet who has a phone. You can think of LiveMD as a global digital hospital on your phone. Anytime and anywhere, virtually anyone can be quickly and safely connected to a certified physician for a live consultation. Anyone can schedule an appointment to talk to a doctor by phone, video, text, or in person. This is our core mission and what we do best.

LiveMD also offers an innovative app that can be securely downloaded directly from the Google Play store. Use the app to talk to a certified doctor in the LiveMD global health network by phone, video, or text from anywhere. With the app, the patient literally has a self-diagnosis tool powered by advanced artificial intelligence capability, in the palm of their hand. After they use the LiveMD app to perform a self-diagnosis, the app then identifies doctors who are available for a consultation and who specialize in that patients specific medical ailment. In the near future, LiveMD will also identify which pharmaceuticals are designed and routinely prescribed to treat that condition.

LiveMD has always advocated for the idea that health care is global and not just local, and must be treated as such. We have led the industry, says Okwara, using our technology with that mindset. This allows us to provide a platform that addresses some of the global health challenges we are experiencing today, and prevent future pandemics.

Organizations such as health insurance companies, business owners and employers, and NGOs can use LiveMD to serve employees and customers. That ensures that those who get the app will receive vital access to the help they need, supported by a global network of doctors.

Okwara adds that, "LiveMD plans to work with governments and provide them with the tools to get real-time COVID-19 updates from their citizens, help triage individuals for covid-19 testing, and help provide citizens the help they desperately need. Our objective is to help governments quickly and efficiently reduce the spread of the virus and save lives. Government institutions can reach LiveMD at gov@mylivemd.com to quickly get onboard the LiveMD Global Health Platform. It takes less than an hour to get onboarded. Because of LiveMDs depth of experience and technological sophistication, the platform can swiftly and strategically respond to individual, local, regional, and global health concerns.

About LiveMD

LiveMD is a Telehealth platform used to increase access to quality healthcare services around the world using its artificial intelligence, big data and telecommunication technologies. Patients across 43 countries use LiveMD to talk to certified doctors by phone, video, and text. They also use LiveMDs artificial intelligence tools for self-diagnosis, virus tracking andmedical testing triaging.You can find more information about LiveMD at http://www.mylivemd.com and you can download the app at http://bitly.com/livemdapp.

LiveMD Media Contact:Emeka Okwarapress@mylivemd.com

Link:
LiveMD Global Telehealth Platform launches artificial intelligence tracking and triaging tools to help combat COVID-19 (CoronaVirus) Pandemic -...